{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T13:49:57Z","timestamp":1648734597916},"reference-count":9,"publisher":"Hogrefe Publishing Group","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Praxis"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:p> Zusammenfassung. Die Sarkoidose ist eine seltene Ursache der Hyperkalz\u00e4mie. Als h\u00e4ufigste Ursachen kommen ein prim\u00e4rer Hyperparathyreoidismus sowie ein malignes Tumorleiden in Frage. Weitere Ursachen k\u00f6nnen eine Vitamin-D-Intoxikation, sonstige granulomat\u00f6se Erkrankungen (Tuberkulose, Pilzinfektionen etc.) oder ein multiples Myelom sein. Aufgrund der breiten Differenzialdiagnose ist eine systematische Abkl\u00e4rung entscheidend, um die korrekte Diagnose zu stellen. Zur Therapie einer Hyperkalz\u00e4mie erfolgt eine Volumensubstitution und anschliessende Gabe von Bisphosphonaten. Bei einer Sarkoidose als Ursache der Hyperkalz\u00e4mie ist zudem eine systemische Steroidtherapie mit Prednisolon indiziert. <\/jats:p>","DOI":"10.1024\/1661-8157\/a003669","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T17:31:50Z","timestamp":1621618310000},"page":"397-402","source":"Crossref","is-referenced-by-count":0,"title":["Eine seltene Ursache der Hyperkalz\u00e4mie"],"prefix":"10.1024","volume":"110","author":[{"given":"Luca","family":"Emmenegger","sequence":"first","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin, Zuger Kantonsspital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Vogetseder","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Pathologie, Luzerner Kantonsspital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bodmer","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin, Zuger Kantonsspital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"101","reference":[{"key":"c1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.103.4.1100"},{"key":"c2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1975"},{"key":"c3","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650061413"},{"key":"c4","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.17-3-270"},{"key":"c5","doi-asserted-by":"publisher","DOI":"10.1016\/j.emc.2018.04.008"},{"key":"c6","doi-asserted-by":"publisher","DOI":"10.1177\/1479973119878713"},{"key":"c7","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21489"},{"key":"c8","doi-asserted-by":"publisher","DOI":"10.1210\/er.2016-1070"},{"key":"c9","unstructured":"Shane E.                   Diagnostic approach to hypercalcemia [Internet]. UpToDate. 2020                   [cited 12.12.2020]. https:\/\/www.uptodate.com\/contents\/diagnostic-approach-to-hypercalcemia?search=hypercalcemia&source=search_result&selectedTitle                   =1~150&usage_type=default&display_rank=1; letzter                   Zugriff: 01.03.2021."}],"container-title":["Praxis"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/econtent.hogrefe.com\/doi\/pdf\/10.1024\/1661-8157\/a003669","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T15:06:02Z","timestamp":1625065562000},"score":1,"resource":{"primary":{"URL":"https:\/\/econtent.hogrefe.com\/doi\/10.1024\/1661-8157\/a003669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":9,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["10.1024\/1661-8157\/a003669"],"URL":"https:\/\/doi.org\/10.1024\/1661-8157\/a003669","relation":{},"ISSN":["1661-8157","1661-8165"],"issn-type":[{"value":"1661-8157","type":"print"},{"value":"1661-8165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5]]}}}